Modeling and Simulation Archives

White Paper

C-QTc and C-QT Analysis: Replacing TQT Studies and Accelerating Cardiovascular Safety Decisions

Replace or waive TQT studies with validated C-QT analysis strategies accepted by FDA, EMA, PMDA.…

Certara2025 年 10 月 3 日

Case Study

Certara 与迪哲强强联手助力舒沃替尼斩获FDA肺癌适应症加速批准

Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…

Certara2025 年 10 月 2 日

Blog

临床药理学差距分析最佳实践

2025 年 9 月 19 日 Submitting your New Drug Application (NDA) to the FDA is the ultimate…

Certara2025 年 9 月 19 日

Announcement

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

RADNOR, Pa. – 2025 年 9 月 17 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…

Certara2025 年 9 月 17 日

Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

–

Certara2025 年 9 月 5 日

Conference

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

Certara2025 年 9 月 4 日

Live Events

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

– London, UK

Certara2025 年 9 月 4 日

On-Demand Webinar

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

Watch leading experts from Pfizer, Merck, Amicus, and Certara discuss how Integrated Evidence can bridge…

Certara2025 年 9 月 3 日

On-Demand Webinar

设计高价值药物研发计划：From Concept to First-in-Human (FIH)

Learn to design drug development programs for First-in-Human (FIH) success with biomarkers, PK/PD modeling, and…

Certara2025 年 8 月 29 日

Conference

BioTechX US 2025

– – Booth

Simona Colucci2025 年 8 月 15 日

建模与模拟

C-QTc and C-QT Analysis: Replacing TQT Studies and Accelerating Cardiovascular Safety Decisions

Certara 与迪哲强强联手助力舒沃替尼斩获FDA肺癌适应症加速批准

临床药理学差距分析最佳实践

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

Redefining Every Stage of Investment (RESI) Seed to Exit

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

设计高价值药物研发计划：From Concept to First-in-Human (FIH)

BioTechX US 2025

订阅时事通讯

快捷链接

解决方案

联系我们